Kairos Pharma Ltd. Skyrocketed

Thu, Jan 16, 2025 at 07:28 PM

Kairos Pharma Ltd. (KAPA:NYSEMKT) rocketted at $1.77, representing a gain of 34.1%. The stock got featured on our News Catalysts scanner on Tue, Jan 07, 2025 at 09:51 AM in the 'MISCELLANEOUS' category. From Fri, Jan 03, 2025, the stock recorded 37.50% Up Days and 44.44% Green Days

The stock spiked on Mon, Jan 13, 2025 at $3.25 with a volume of 113M+.

About Kairos Pharma Ltd. (KAPA:NYSEMKT)

Kairos Pharma is a clinical-stage biopharmaceutical company advancing therapeutics for cancer patients that are designed to overcome key hurdles in immune suppression and drug resistance.

Top 10 Gainers:

Biomerica, Inc. (BMRA:NASDAQ), 108.75%
FOXO Technologies Inc. Class A (FOXO:NYSEMKT), 57.97%
AEON Biopharma Inc. Class A (AEON:NYSEMKT), 55.93%
Flexible Solutions International Inc. (FSI:NYSEMKT), 52.85%
Katapult Holdings Inc. (KPLT:NASDAQ), 46.82%
Wang & Lee Group Inc. (WLGS:NASDAQ), 40.28%
LatAmGrowth SPAC (LATG:NASDAQ), 40%
Arqit Quantum Inc. (ARQQ:NASDAQ), 37.35%
DatChat Inc. (DATS:NASDAQ), 37.32%
Kairos Pharma Ltd. (KAPA:NYSEMKT), 34.09%